MaxCyte Share Price

MaxCyte Share Price

NASDAQ: MXCT | Micro Cap | Healthcare
$1.29
+$0.04 (2.79%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

MaxCyte Stock Performance

Open
$1.31
Prev. Close
$1.25
Circuit Range
N/A
Day Range
$1.24 - $1.31
Year Range
$0.65 - $1.80
Volume
1,35,777
Average Traded
$1.28

MaxCyte Share Price Today

As of 20 November 2026, MaxCyte, Inc.'s share price is $1.29. The stock opened at $1.31, compared to its previous close of $1.25. During today's trading session, MaxCyte, Inc.'s share price traded between $1.24 and $1.31, with an average price of $1.27. Over the past 52 weeks, the stock has recorded a high of $1.80 and a low of $0.65. In terms of performance, MaxCyte, Inc.'s share price has risen by 6.61% over the last six months and is down 26.29% on a year-on-year basis.

MaxCyte Share Price Chart

Line chart of the MaxCyte price trend over the selected period. The price rose overall, ranging from 1.14 to 1.25, ending at 1.25.
$1.24$1.31
L
Show Current Price
H

MaxCyte Stock Fundamentals & Key Indicators

Market Cap
$137.29M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.27
Revenue (TTM)
$33.03B
Return On Equity (TTM)
-18.54%
Profit Margin
-135.12%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
50.42%

MaxCyte Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$7.30$9.65$7.27$10.15
Net Profit-$9.60-$4.75-$8.87-$4.76
Net Profit Margin-131.51%-49.22%-122.01%-46.90%
Income ChangeN/A50.52%-86.74%46.34%

MaxCyte Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$44.26$41.29$38.63$33.03
Net Profit-$23.57-$37.92-$41.06-$44.63
Net Profit Margin-53.25%-91.84%-106.29%-135.12%
Income ChangeN/A-60.88%-8.28%-8.69%

MaxCyte Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets84.1467.7978.0834.39
Current Assets118.37171.68190.19252.27
Total Assets202.51239.47268.27286.65
Non Current Liabilities16.7517.4418.2517.26
Current Liabilities14.2715.7817.8615.43
Total Liabilities31.0233.2236.1132.69
Shareholders' Equity171.49206.25232.17253.97

MaxCyte Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-34.41-27.61-21.69-14.78
Investing25.946.9354.98-24.82
Financing0.662.062.142.89

About MaxCyte

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

MaxCyte Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.64
$1.29
-18.55%
Oct 2026
$1.14
$1.59
+41.33%
Sep 2026
$1.26
$1.13
-12.11%
Aug 2026
$1.06
$1.28
+21.33%
Jul 2026
$1.24
$1.05
-14.23%
Jun 2026
$1.20
$1.23
+1.65%
May 2026
$0.86
$1.21
+37.66%
Apr 2026
$0.70
$0.88
+24.86%
Mar 2026
$0.80
$0.70
-13.19%
Feb 2026
$0.90
$0.81
-11.27%
Jan 2026
$1.55
$0.91
-40.84%
Dec 2025
$1.75
$1.54
-11.71%

MaxCyte Share Price FAQs